Dupilumab-PEdiatric Skin Barrier Function and LIpidomics STudy in Patients With Atopic Dermatitis

Clinical trial NCT04718870 · COMPLETED

Trial details

NCT number: NCT04718870
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Dermatitis Atopic

Start date: 2021-02-19
Primary completion: 2022-09-07
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.